Deldacan, Baby Girl 2 .

HRN: 22-63-20  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/24/2023
CEFTAZIDIME 1GM (VIAL)
02/24/2023
03/03/2023
IV
25mg
BID
Empiric
Waiting Final Action 
02/25/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/25/2023
03/04/2023
IV DRIP
8mg
TID
Empiric
Waiting Final Action 
02/27/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
02/27/2023
03/06/2023
IVTT
4.8mg
Q48hours
NEONATAL SEPSIS, RDS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: